Fennec Pharmaceuticals (FENC) Gross Profit (2023 - 2026)

Fennec Pharmaceuticals (FENC) has 3 years of Gross Profit data on file, last reported at $12.0 million in Q4 2025.

• Quarterly Gross Profit rose 65.56% year-over-year to $12.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $40.9 million (down 7.84% YoY) and the FY2025 annual result came in at $40.9 million, down 7.84% from the prior year.
• Gross Profit climbed to $12.0 million in Q4 2025, from $11.8 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $24.8 million in Q1 2024 to a low of $1.6 million in Q1 2023.
• A 3-year average of $8.8 million and a median of $7.8 million in 2024 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2024 — Gross Profit surged 1469.34% — and 2025, when it slumped 66.25%.
• Tracing FENC's Gross Profit over 3 years: stood at $9.0 million in 2023, then decreased by 19.82% to $7.3 million in 2024, then surged by 65.56% to $12.0 million in 2025.
• The last three Gross Profit figures came in at $12.0 million (Q4 2025), $11.8 million (Q3 2025), and $8.7 million (Q2 2025), per Business Quant data.